Illuminating Protein Dynamics: Novel Insights from High-Speed Atomic Force Microscopy

A recent research article in ScienceDirect.com details a breakthrough in visualizing the rapid, complex movements of proteins using high-speed atomic force microscopy (HS-AFM). This cutting-edge imaging technology allows scientists to…

Continue Reading Illuminating Protein Dynamics: Novel Insights from High-Speed Atomic Force Microscopy

Madrigal Pharmaceuticals Nears EU Approval for REZDIFFRA, Expanding Hope for MASH Patients

Madrigal Pharmaceuticals is making significant strides in its mission to address metabolic dysfunction-associated steatohepatitis (MASH), as the company’s lead drug, REZDIFFRA, edges closer to regulatory approval in the European Union.…

Continue Reading Madrigal Pharmaceuticals Nears EU Approval for REZDIFFRA, Expanding Hope for MASH Patients

Madrigal Pharmaceuticals’ REZDIFFRA Shines as GLP-1 Drugs Approach the MASH Market

Madrigal Pharmaceuticals has recently captured significant attention in the race to treat metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH). As the landscape of liver disease therapeutics evolves,…

Continue Reading Madrigal Pharmaceuticals’ REZDIFFRA Shines as GLP-1 Drugs Approach the MASH Market

Beyond Reason

Patient Worthy is grateful to our partner Elephants & Tea for providing the following article by Laura DeKraker Lang-Ree, a cancer caregiver to her daughter Cecilia who survived childhood leukemia.…

Continue Reading Beyond Reason

Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions

Cure Rare Disease (CRD), a pioneering nonprofit biotechnology organization, has announced the addition of new scientific and strategic leaders, marking a significant step forward in its mission to develop therapies…

Continue Reading Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions